Literature DB >> 28584016

Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel CACNA1D Mutation.

Geok Chin Tan1, Giulia Negro1, Alexandra Pinggera1, Nur Maya Sabrina Tizen Laim1, Isa Mohamed Rose1, Jiri Ceral1, Ales Ryska1, Long Kha Chin1, Nor Azmi Kamaruddin1, Norfilza Mohd Mokhtar1, A Rahman A Jamal1, Norlela Sukor1, Miroslav Solar1, Joerg Striessnig1, Morris Jonathan Brown1, Elena Aisha Azizan2.   

Abstract

Mutations in KCNJ5, ATP1A1, ATP2B3, CACNA1D, and CTNNB1 are thought to cause the excessive autonomous aldosterone secretion of aldosterone-producing adenomas (APAs). The histopathology of KCNJ5 mutant APAs, the most common and largest, has been thoroughly investigated and shown to have a zona fasciculata-like composition. This study aims to characterize the histopathologic spectrum of the other genotypes and document the proliferation rate of the different sized APAs. Adrenals from 39 primary aldosteronism patients were immunohistochemically stained for CYP11B2 to confirm diagnosis of an APA. Twenty-eight adenomas had sufficient material for further analysis and were target sequenced at hot spots in the 5 causal genes. Ten adenomas had a KCNJ5 mutation (35.7%), 7 adenomas had an ATP1A1 mutation (25%), and 4 adenomas had a CACNA1D mutation (14.3%). One novel mutation in exon 28 of CACNA1D (V1153G) was identified. The mutation caused a hyperpolarizing shift of the voltage-dependent activation and inactivation and slowed the channel's inactivation kinetics. Immunohistochemical stainings of CYP17A1 as a zona fasciculata cell marker and Ki67 as a proliferation marker were used. KCNJ5 mutant adenomas showed a strong expression of CYP17A1, whereas ATP1A1/CACNA1D mutant adenomas had a predominantly negative expression (P value =1.20×10-4). ATP1A1/CACNA1D mutant adenomas had twice the nuclei with intense staining of Ki67 than KCNJ5 mutant adenomas (0.7% [0.5%-1.9%] versus 0.4% [0.3%-0.7%]; P value =0.04). Further, 3 adenomas with either an ATP1A1 mutation or a CACNA1D mutation had >30% nuclei with moderate Ki67 staining. In summary, similar to KCNJ5 mutant APAs, ATP1A1 and CACNA1D mutant adenomas have a seemingly specific histopathologic phenotype.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  adrenal; aldosterone; primary hyperaldosteronism; zona fasciculata; zona glomerulosa

Mesh:

Substances:

Year:  2017        PMID: 28584016     DOI: 10.1161/HYPERTENSIONAHA.117.09057

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  19 in total

1.  Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.

Authors:  Yuhong Yang; Celso E Gomez-Sanchez; Diana Jaquin; Elke Tatjana Aristizabal Prada; Lucie S Meyer; Thomas Knösel; Holger Schneider; Felix Beuschlein; Martin Reincke; Tracy Ann Williams
Journal:  Hypertension       Date:  2019-08-26       Impact factor: 10.190

2.  In situ metabolomics of aldosterone-producing adenomas.

Authors:  Masanori Murakami; Yara Rhayem; Thomas Kunzke; Na Sun; Annette Feuchtinger; Philippe Ludwig; Tim Matthias Strom; Celso Gomez-Sanchez; Thomas Knösel; Thomas Kirchner; Tracy Ann Williams; Martin Reincke; Axel Karl Walch; Felix Beuschlein
Journal:  JCI Insight       Date:  2019-09-05

Review 3.  Aging and Adrenal Aldosterone Production.

Authors:  Kazutaka Nanba; Anand Vaidya; William E Rainey
Journal:  Hypertension       Date:  2017-12-11       Impact factor: 10.190

Review 4.  What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics.

Authors:  C Christofer Juhlin; Ozgur Mete; Jérôme Bertherat; Thomas J Giordano; Gary D Hammer; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2021-02-03       Impact factor: 3.943

Review 5.  Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.

Authors:  Georgia Pitsava; Fabio R Faucz; Constantine A Stratakis; Fady Hannah-Shmouni
Journal:  Curr Cardiol Rep       Date:  2022-07-16       Impact factor: 3.955

Review 6.  Pathophysiology of bilateral hyperaldosteronism.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

Review 7.  Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Koshiro Nishimoto
Journal:  Horm Metab Res       Date:  2020-04-14       Impact factor: 2.936

8.  Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.

Authors:  Yuto Yamazaki; Kei Omata; Yuta Tezuka; Yoshikiyo Ono; Ryo Morimoto; Yuzu Adachi; Kazue Ise; Yasuhiro Nakamura; Celso E Gomez-Sanchez; Yukiko Shibahara; Takumi Kitamoto; Tetsuo Nishikawa; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

9.  Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.

Authors:  Zeng Guo; Kazutaka Nanba; Aaron Udager; Brett C McWhinney; Jacobus P J Ungerer; Martin Wolley; Moe Thuzar; Richard D Gordon; William E Rainey; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

Review 10.  Approaches to Gene Mutation Analysis Using Formalin-Fixed Paraffin-Embedded Adrenal Tumor Tissue From Patients With Primary Aldosteronism.

Authors:  Kazutaka Nanba; William E Rainey; Aaron M Udager
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-29       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.